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Abstract
Background: Phosphoinositides mediate one of the intracellular signal transduction pathways and
produce a class of second messengers that are involved in the action of hormones and
neurotransmitters on target cells. Thyroid hormones are well known regulators of lipid metabolism
and modulators of signal transduction in cells. However, little is known about phosphoinositides
cycle regulation by thyroid hormones. The present paper deals with phosphoinositides synthesis
de novo and acylation in liver at different thyroid status of rats.
Results: The experiments were performed in either the rat liver or hepatocytes of 90- and 720-
day-old rats. Myo-[3H]inositol, [14C]CH3COONa, [14C]oleic and [3H]arachidonic acids were used
to investigate the phosphatidylinositol (PtdIns), phosphatidylinositol 4-phosphate and
phosphatidylinositol 4,5-bisphosphate (PtdInsP2) synthesis. 1-methyl, 2-mercaptoimidazol-induced
hypothyroidism was associated with the decrease of myo-[3H]inositol and [3H]arachidonic acids
incorporation into liver phosphoinositides and total phospholipids, respectively. The thyroxine (L-
T4) injection to hypothyroid animals increased the hormones contents in blood serum and PtdInsP2
synthesis de novo as well as [3H]arachidonic acids incorporation into the PtdIns and PtdInsP2.
Under the hormone action, the [14C]oleic acid incorporation into PtdIns reduced in the liver of
hypothyroid animals. A single injection of L-T4 to the euthyroid [14C]CH3COONa-pre-treated
animals or addition of the hormone to a culture medium of hepatocytes was accompanied by the
rapid prominent increase in the levels of the newly synthesized PtdIns and PtdInsP2 and in the mass
of phosphatidic acid in the liver or the cells.
Conclusions:  The data obtained have demonstrated that thyroid hormones are of vital
importance in the regulation of arachidonate-containing phosphoinositides metabolism in the liver.
The drug-induced malfunction of thyroid gland noticeably changed the phosphoinositides synthesis
de novo. The L-T4 injection to the animals was followed by the time-dependent increase of
polyphosphoinositide synthesis in the liver. The both long-term and short-term hormone effects
on the newly synthesized PtdInsP2 have been determined.
Background
The phosphoinositides is a family of lipids which mem-
bers play an essential role in the receptor-mediated intra-
cellular signaling cascades, vesicle trafficking and
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cytoskeletal rearrangements [for review see [1,2]] and,
therefore, are crucial for the adaptation and survival of
cells. Because of their importance in numerous signaling
events, the phosphoinositides require an absolutely tight
temporal and spatial regulation of synthesis and degrada-
tion, enabling the cell to maintain organelle identity and
housekeeping functions. A rapid agonist-dependent burst
of phosphoinositides biosynthesis was the first feature of
the polyphosphoinositide signaling pathway to be discov-
ered, illustrating that synthesis is tightly coupled to
degradation.
The two pools of phosphoinositides are supposed to exist
in the cells [3,4]. One of these is sensitive to the hormone-
induced hydrolysis, and the other is hydrolysis-insensi-
tive. The biosynthesis of phosphatidylinositol (PtdIns) is
the two-component process composed of cytidyltrans-
ferase followed by a synthase [for review see [5,6]]. The
first detailed study of the occurrence and localization of
the PtdIns synthase activity in various tissues from guinea
pig was carried out by Benjamins and Agranoff [7]. They
detected the enzyme activity in all the tissues tested,
including brain, liver, kidney, heart, lung and spleen. The
PtdIns synthase activity was also detected in the endoplas-
mic reticulum, plasma membranes, Golgi apparatus and
nuclei. The hormone-sensitive pool of phosphatidylinosi-
tol 4,5-bisphosphate (PtdInsP2) in the plasma [8] and
nuclear [9] membranes re-synthesized in these membrane
fractions. The PtdIns synthesized de novo in the endoplas-
mic reticulum could be converted to the glycosylPtdIns or
transferred by transfer proteins to other cellular compart-
ments where the lipid was used for the phosphatidylinosi-
tol 4-phosphate (PtdInsP), PtdInsP2  and other
polyphosphoinositides production [10,11].
The regulation of the key enzymes of the PtdIns synthesis
pathway: the CDP-diacylglycerol (DAG) synthase and
PtdIns synthase were examined [12]. Expression of the
PtdIns synthase gene caused the overproduction of the
both of the PtdIns synthase and PtdIns:inositol exchange
reactions, indicating that the gene encode the both
enzymes. However, the overexpression of PtdIns synthase
or CDP-DAG synthase alone or in combination in the
COS-7 cells did not enhance the rate of the PtdIns biosyn-
thesis and did not result in a significant proportional
increase in the CDP-DAG and PtdIns cellular levels. The
CDP-DAG synthase activity was inhibited by polyphosph-
oinositides in vitro [13]. This makes possible to suggest
that these end products of the pathway may function as
the feedback inhibitors of PtdIns biosynthesis in vivo. The
PtdIns synthase activity has been shown to be upregulated
after the hormone-induced phospholipase C (PLC) medi-
ated hydrolysis of phosphatidylinositol-polyphosphates
[14,15]. The efficiency of the PtdIns synthesis is depend-
ent on the CDP-DAG fatty acids composition [for review
see [5,6]]. In the bovine brain, the CDP-DAG has been
shown to present predominantly as the 1-steroyl, 2-ara-
chidonyl which are also the main PtdIns components.
Thyroid hormones are of vital importance in maintaining
the initial level of phospholipids in cell membranes and
fatty acids composition of the lipids. On the other hand,
there is a little literature regarding the hormone regulation
of phosphoinositides exchange. The levels of [32P]phos-
phoinositides and inositol 1,4,5-trisphosphate were
found to be significantly lower in the hypothyroid rat
hearts [16]. The effect of hypothyroidism on the insulin-
and epinephrine-stimulated phosphoinositide metabo-
lism has been investigated in the rat adipocytes [17]. The
hypothyroidism enhanced the insuline-mediated phos-
phoinositides synthesis. The hypothyroidism caused a sig-
nificant increase in both the basal and ouabain-
stimulated accumulation of [3H]inositol phosphate in the
hypothalamic slices, whereas the thyroxine (L-T4) com-
pletely restored the hypothalamic [3H]inositol phosphate
formation [18]. The results indicate that the negative feed-
back action of the thyroid hormone may occur at a post-
receptor site in the hypothalamus. The thyroid hormones
might participate in regulating the muscarinic cholinergic
neurotransmission in the adult rats striatum via the stim-
ulatory action on the inositol phosphate formation in the
[3H]inositol pre-labeled tissue [19]. Thus, it becomes evi-
dent that the thyroid gland malfunction leads to the
prominent disturbances of signal transduction in the adi-
pocytes and nervous cells via the changes of phosphoi-
nositides metabolism.
In the paper, we examined the influence of the drug- and
L-T4-altered thyroid status of animals on the phosphoi-
nositides synthesis in the liver. Thus, it was determined
that the hypothyroidism decreased considerably the levels
of the newly synthesized lipids in the liver but thyroid
hormones increased the synthesis of the polyphosphoi-
nositides de novo and the arachidonic acid incorporation
into the PtdIns and PtdInsP2. A single injection of the L-T4
to the euthyroid rats lead to the rapid and transient
decrease of the newly synthesized PtdInsP2 followed by
the increase of the PtdIns and PtdInsP2 levels in the liver.
Results and Discussion
The present paper considers the influence of thyroid func-
tional status on the phosphoinositides synthesis in the
liver. To determine the role of thyroid hormones in the
regulation of phosphoinositides synthesis de novo and
lipids fatty acid remodeling, the euthyroid, MMI (1-
methyl, 2-mercaptoimidazol)- and MMI+L-T4-treated rats
and intact animals after the single hormone injection has
been studied.Lipids in Health and Disease 2004, 3:28 http://www.lipidworld.com/content/3/1/28
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It has been reported that the L-T4 induced hydrolysis of
PtdInsP2 and inositol phosphates and DAG formation at
the early stages of hormone action on the [14C]oleic and
[14C]linoleic acid pre-labeled hepatocytes of adult 90-day-
old rats [20,21]. The L-T4-mediated PLC activation was
accompanied by the protein kinase C (PKC) translocation
to membranes [20] and PKC dependent stimulation of
mitogen-activated protein kinase [22] and acylation of
phospholipids and triacylglycerol synthesis [23]. The
PtdInsP2-specific PLC activation in the L-T4-stimulated
cells was a short-lived event. The hormone-stimulated rise
in inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) was fol-
lowed by its conversion into the biologically inactive
inositol 1,4 -bisphosphate and inositol 1-phosphate [21].
It is known that after the receptor-triggered hydrolysis of
phosphatidylinositol-polyphosphates the phospholipid
must be resynthesized in order to maintain a constant
level of phosphoinositides in the membranes. A single
injection of L-T4 to the 90-day-old rats leads to the rapid
and sustained increase in the L-T4 and triiodothyronine
(L-T3) levels in blood serum (Table 1), the content of the
newly synthesized PtdIns and transient decrease the
PtdInsP2 level in the [14C]CH3COONa-pre-labeled liver,
which was followed by the polyphosphoinositide level
increase (Figure 1A). Taking into account that the
PtdInsP2 suppresses the key enzymes of PtdIns synthesis
[13], the transient hormone-stimulated and phospholi-
pase C-mediated [20,21] drop of the newly synthesized
polyphosphoinositide in the liver cells was supposed to
be the stimulus for the PtdIns synthesis. The L-T4 admin-
istration to the old 720-day-old rats did not change the
newly synthesized PtdIns and PtdInsP2 levels in the liver
(Figure 1B) although increased thyroid hormones con-
tents in blood serum (Table 1). It has been shown that the
thyroid hormones are unable to stimulate rapidly the
phospholipase C in the [14C]CH3COONa-pre-labeled
liver slices and hepatocytes of old animals [24]. These
observations, together with the earlier data [20,21], sug-
gest that the L-T4 stimulates rapidly and nongenomicaly
the phosphoinositides degradation and resynthesis in the
liver of adult rats and does not act on the phosphoi-
nositides synthesis in the cells with the disability of
polyphosphoinositide signaling at old age.
In addition to its established role as a precursor for the sig-
naling molecules (Ins(1,4,5)P3  and inositol 3,4,5-tri-
sphosphate), the PtdInsP2  is now recognized as an
important plasma membrane signal that activates the PLD
[for review see [25]] and thus establishes the sites for
vesicular trafficking, membrane movement and cytoskele-
tal assembly. It has been demonstrated in the mammalian
cells that the PtdInsP2 is a membrane-associated cofactor
of PLD [26,27]. The rapid stimulation of the PtdInsP2-spe-
cific PLC by the L-T4 in the rat hepatocytes of adult 90-day-
old rats was followed by the prominent PLD activation
[20]. The PLD response in the stimulated cells was
reduced by the both PKC inhibitor and a high affinity lig-
and of PtdInsP2 – neomycin. Neomycin does not directly
interact with PLC and PLD but interacts with the endog-
enous membrane PtdInsP2. Inclusion of the PtdInsP2 in
mixed phosphatidylcholine/phosphatidylethanolamine
liposomes [26] and stimulation of the phosphoinositide
5-kinase by an addition of the MgATP [27] greatly poten-
tiates the PLD activation. Direct evidence that phosphoi-
nositide kinase is involved in the PLD activation comes
with the use of an inhibitory antibody for this enzyme
[26]. The results strongly demonstrate that the PLD activa-
tion requires the enhanced PtdInsP2 synthesis and the
resting cellular levels of PtdInsP2  are insufficient for
enzyme stimulation. The role of PKC has been deter-
mined in the regulation of PtdInsP2synthesis in the liver
[28] and other cell types [29]. The PKC translocation to
membranes and enzyme activation are initial steps in the
PLD [for review see [25]] and phosphoinositide 5-kinase
[29] stimulation. The lack of PKC/PLD response [24] cor-
relates with the suppressed ability of the L-T4 to stimulate
the PtdInsP2 synthesis in the liver cells of the 720-day-old
rats (Fig. 1B). However, in the liver cells of adult animals
the L-T4  -induced PKC activation and elevation of
PtdInsP2 synthesis might lead to the PLD activation.
To determine whether the altered thyroid functional sta-
tus influences the phosphoinositides synthesis, we stud-
ied the myo-[3H]inositol incorporation into the PtdIns,
PtdInsP and PtdInsP2 in the liver of the drug- and L-T4 -
treated animals. The MMI administration to the rats was
Table 1: Thyroxine and triiodothyronine contents in the blood 
serum of the rats of different thyroid states and age.
Animals T4 T3
Adult control 128 ± 3.80 1.21 ± 0.20
Adult MMl-treated 29.5 ± 5.00** 0.83 ± 0.01*
Adult MMl+T4-treated 57.3 ± 7.30*** 1.61 ± 0.10***
Adult T4-treated 1 654 ± 50.0** 5.78 ± 0.20**
2 675 ± 98.5** 15.9 ± 4.10**
Old control 70.7 ± 11.6 1.37 ± 0.07
Old T4-treated 1 730 ± 15** 5.8 ± 1.5**
2 537 ± 128** 4.9 ± 0.0**
The T3 and T4 contents in the blood serum were determined by 
radioimmunoassays kits. The amount of thyroid hormones in serum 
was represented as nmol per liter. Treatment of the rats by MMl was 
performed as described in "Materials and Methods". T4 (200 mg/100 g 
weight) was injected to the MMl-treated rats 48 h prior to killing or 
normal rats 15 (1) and 60 (2) min prior to killing. Results are mean ± 
S.E. of 6–8 individual experiments performing in duplicate. In the 
Tables 1–2 and Figures 1–3 one experiment is equivalent to 
measurement of the parameters studied in a sample of liver of single 
animal. * P < 0.05 vs. control, ** P < 0.001 vs. control, *** P < 0.05 vs. 
MMl-treated rats.Lipids in Health and Disease 2004, 3:28 http://www.lipidworld.com/content/3/1/28
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Short-term effects of L-thyroxine on the newly synthesized phosphoinositides levels in liver Figure 1
Short-term effects of L-thyroxine on the newly synthesized phosphoinositides levels in liver. Panel A – 90-day-old rats; panel B 
– 720-day-old rats. The liver lipids were labeled by [14C]CH3COONa as described in "Materials and Methods". The L-T4 (200 
µg/100 g weight) was injected to the normal rats 15 and 60 min prior to killing. The lipids were extracted and separated as 
described in "Materials and Methods" and the radioactivity was determined by a liquid scintillation counter. Results are mean ± 
S.E. of six experiments performed in duplicate.Lipids in Health and Disease 2004, 3:28 http://www.lipidworld.com/content/3/1/28
Page 5 of 10
(page number not for citation purposes)
Phosphoinositides synthesis in the liver of rats of different thyroid status Figure 2
Phosphoinositides synthesis in the liver of rats of different thyroid status. Panel A shows myo-[3H]inositol incorporation into 
the lipids of control rats. Panel B shows the lipid precursor incorporation into the lipids of liver of MMI-treated animals. Panel 
C shows effect of L-T4 on phosphoinositides synthesis in liver of MMI-treated rats. Treatment of the 90-day-old rats by MMI 
was performed as described in ''Materials and Methods''. L-T4 (200 µg/100 g weight) was injected to the MMI-treated rats 48 h 
prior to killing. Control rats received the same volume of 0.9% NaCl. Liver slices were incubated in the presence of the myo-
[3H]inositol and lipids were extracted and separated as described in ''Materials and Methods'' and the radioactivity was deter-
mined by liquid scintillation counter. Results are mean ± S.E. of 6 – 8 individual experiments performed in duplicate. *P < 0.05 
vs. control, **P < 0.05 vs. MMI-treated rats.Lipids in Health and Disease 2004, 3:28 http://www.lipidworld.com/content/3/1/28
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found to be accompanied by the decreased myo-[3H]inosi-
tol incorporation into the PtdIns, PtdInsP and PtdInsP2 in
the liver (Figure 2A,2B) and drop of thyroid hormones
levels in the blood serum (Table 1). The data obtained are
consistent with the observations [30] of the drug-induced
thyroid gland malfunction. The L-T4  injection to the
hypothyroid rats increased the T4 and T3 contents in blood
serum (Table 1), the myo-[3H]inositol incorporation into
the PtdInsP2 (Figure 2B,2C) and did not changed the lev-
els of the other newly synthesized phosphoinositides in
the hypothyroid liver.
Thyroid hormones stimulate lipogenesis in the liver by
inducing the enzymes in the lipogenic pathway. The acyl-
CoA-glycerol-3-phosphate acyltransferase, which is
known to catalyze a rate-limiting step for the synthesis of
phosphatidic acid in the rat liver, is dependent on the thy-
roid gland function [31]. The L-T4 administration to the
euthyroid rats increased the incorporation of the [14C]pal-
mitic acid into the phosphatidic acid and PtdInsP2 in the
isolated hepatocytes [28]. The results obtained in the
present work demonstrated that the L-T4 addition to the
culture medium significantly increased the mass of phos-
phatidic acid and did not change the content of PtdIns in
the hepatocytes (Table 2). The hormone addition to the
culture medium caused the prominent and rapid (within
60 min of cells incubation) increase in the phosphatidic
acid synthesis de novo and [14C]palmitic acid incorpora-
tion into the PtdInsP2 and did not change the PtdIns labe-
ling in the isolated hepatocytes [28]. It can be said that the
L-T4 stimulates the PtdIns precursor synthesis and accu-
mulation in the liver cells in the both long- and short-
term manner. The thyroid hormone activation of phosph-
oinositide synthesis in the liver cells can be supposed to
go through an enhancement of the glycerol-3-phosphate
acylation, phosphatidic acid accumulation and its conver-
sion into phosphoinositides. Besides, the phosphatidic
acid can activate the phosphoinositide 5-kinase [32] and
thus stimulate the PtdInsP2 synthesis in the hormone-
treated liver cells. Considering that the hormone could
rapidly (within 60 min) stimulate the phosphatidic acid
and PtdInsP2 accumulation and did not change the PtdIns
content in the liver cells, it could be assumed that in such
case the L-T4 increases PtdInsP2 synthesis via phosphoi-
nositide 5-kinase activation rather than the lipid synthesis
de novo.
It is well documented that the efficiency of polyphoshoi-
nositide derived second messanger DAG in signaling
pathways is closely dependent on the degree of its unsatu-
ration. The unsaturated fatty acids are incorporated into
the sn-2 position of the phospholipids by the deacylation-
reacylation reactions. Some investigations demonstrated
the changes of the fatty acid composition of membrane-
ous lipids at the hypo- and hyperthyroid state of the rats
[for review see [33]]. There were generally a reciprocal
changes in membranes arachidonic acid contents,
namely, a decrease in the hypothyroidism and its increase
after the thyroid hormone injection. The L-T3 administra-
tion to the euthyroid rats increases the saturated fatty
acids and arachidonate/linoleate ratio of PtdIns in the
liver cell mitochondria [34].
The hypothyroidism was associated with the decrease in
the [3H]arachidonic acid incorporation into the liver total
phospholipids (Figure 3A). The [14C]oleic acid labeling of
the liver phospholipids was not dependent on the thyroid
status of the rats (Figure 3C). The L-T4injection to the
hypothyroid animals completely abolished the drug-
induced changes of the [3H]arachidonic acid incorpora-
tion into the liver total phospholipids (Figure 3A). The
hypothyroidism was associated with the increased arachi-
donic acid conversion into the prostaglandine E2 in the
adult rat liver [35]. The L-T4 administration to the thyroid-
ectomysed animals reduced the prostaglandine E2 synthe-
sis and its content in the liver. Conceivably, the thyroid
hormones regulating the arachidonic acid metabolism
could maintain the initial level of polyunsaturated phos-
pholipids in the liver cells.
The MMI did not change markedly the 14C/3H-labeling of
PtdIns and PtdInsP2 in the liver slices (Figure 3B,3D). The
L-T4 administration to the rats increased the incorporation
of [3H]arachidonic acid into the PtdIns and PtdInsP2 in
the hypothyroid liver (Table 3B) and decreased the con-
tent of the oleate-labeled PtdIns in the liver slices (Table
3D). The incorporation of the [14C]oleic acid into the
PtdInsP2 did not differ between the liver slices of control,
drug- and hormone-treated animals. As can be seen from
the Table 1, the MMI reduced the T4 and T3 levels in the
blood serum, but did not remove completely the hor-
mones from organism. The T3 content in the serum of the
drug-treated animals was relatively high as compared with
control animals. However, the MMI reduced the T4 level
by 77%. The T4 administration to the MMI-treated rats
increased significantly T3 and T4 contents in the serum. It
Table 2: Rapid effect of L-T4 on phosphatidic acid and 
phosphatidylinositol contents in the isolated hepatocytes.
Lipid Cells:
Control L-T4 -treated
Phosphatidic acid 9,29 ± 0,71 17,7 ± 2,94 *
Phosphatidylinositol 13,6 ± 0,62 13,7 ± 1,83
Hepatocytes were isolated from the liver of adult 90-day-old rats and 
lipids contents were analyzed as described in "Materials and Methods" 
and expressed as % of total phospholipids. Hepatocytes were treated 
with 100 nM NaOH (control) or 10 nM of L-T4 for 30 min. Results are 
mean ± S.E. of six experiments. * p < 0,05 vs. control.Lipids in Health and Disease 2004, 3:28 http://www.lipidworld.com/content/3/1/28
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Incorporation of [3H]arachidonic and [14C]oleic acid into liver total phospholipids and phosphoinositides of rats of different  thyroid status Figure 3
Incorporation of [3H]arachidonic and [14C]oleic acid into liver total phospholipids and phosphoinositides of rats of different 
thyroid status. Panel A and B show [3H]arachidonic acid incorporation into total phospholipids and phosphoinositides of rats of 
different thyroid status, respectively. Panel C and D show the [14C]oleic acid incorporation into total phospholipids and phos-
phoinositides of rats different thyroid status, respectively. Treatment of the 90-day-old rats by MMI was performed as 
described in "Materials and Methods". L-T4 (200 µg/100 g weight) was injected to the MMI-treated rats 48 h prior to killing. 
Control rats received the same volume of 0.9% NaCl. Liver slices were incubated in the presence of the [3H]arachidonic or 
[14C]oleic acid and lipids were extracted and separated as described in ''Materials and Methods'' and the radioactivity was 
determined by liquid scintillation counter. Results are mean ± S.E. of 6 – 8 individual experiments performed in duplicate. *P < 
0.05 vs. control, **P < 0.05 vs. MMI-treated rats.Lipids in Health and Disease 2004, 3:28 http://www.lipidworld.com/content/3/1/28
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seems possible that the 14C/3H fatty acids incorporation
into the phosphoinositides was rather regulated by the T3
than T4, although the both hormones are participated in
the regulation of the other phospholipids acylation in the
rat liver.
Conclusions
The present data have demonstrated that the phosphoi-
nositides synthesis de novo and arachidonic acid incorpo-
ration into phospholipids are strongly dependent on the
thyroid status of organism. The marked enrichment of
animal cell phosphoinositides in arachidonate and the
results obtained suggest an important role of the thyroid
hormones in the regulation of polyunsaturated PtdIns
and PtdInsP2 synthesis, which are the predominant sub-
strates of PLC in the numerous signaling pathways. The
both long-term and short-term effects of hormone on
lipid synthesis have been determined (Figure 4). The L-T4
stimulates rapidly and nongenomicaly the PtdInsP2 degra-
dation and resynthesis in the liver of the adult rats and
does not act on the phosphoinositides metabolism in the
cells with the PLC/PKC signaling disability. Besides, the L-
T4  stimulates the polyphosphoinositides synthesis de
novo via the long lag period of time essential to hormone
interaction with nuclear receptors and stimulation of pro-
tein synthesis [36,37]. Considering that the PtdInsP2 par-
ticipates in the activation of different enzymes (the PLD,
protein- and lipid-kinases) involved in the signal trans-
duction in the stimulated cells, the abnormalities of the
phosphoinositides synthesis at different pathological
states of thyroid gland could disturb other hormones sig-
naling in the target cells.
Materials and Methods
Materials
myo-[3H]-inositol (58 mCi/mmol), [14C]oleic acid (58
mCi/mmol) and [3H]arachidonic acid (60 Ci/mmol) –
Amersham Corp. and [14C]CH3COONa (25 mCi/mmol)
– BPO Isotop (Russia); silica gel from Woelm (Germany).
Phosphatidylinositol, phosphatidylinositol 4-phosphate
and phosphatidylinositol 4,5-bisphosphate lipid stand-
ards were obtained from Sigma (USA). T4 and 1-methyl, 2-
mercaptoimidazol were from Zdorov'e Trudyaschikhsya
(Kharkov, Ukraine). T4 and T3  radioimmunoassay kits
were from Minsk (Belarussia). Other chemicals used were
of chemically pure grade.
Animals
90- and 720-day-old male Wistar rats, which had a free
access to food and water and were kept at 24°C on a cycle
of 12 h light/12 h darkness were used for experiments. The
MMI was injected intraperitoneally (1 mg/100 g weight)
in 0.9% NaCl to the experimental animals every day dur-
ing 16 days-experiment. In some cases, the MMI-treated
rats were injected intraperitoneally by T4 (200 µg/100 g
weight) 48 h prior to killing. Besides, T4 (200 µg/100 g
weight) was injected to the normal rats 15 and 60 min
prior to killing. Control rats received 0.9% NaCl of the
same volume. The animals were starved overnight prior to
experiment. The thyroid state of rats was monitored by
radioimmunological determination of the T4 and T3 in
blood serum.
Experiments with Liver Homogenates and Slices
The 1 mCi of [14C]CH3COONa was intraperitoneally
injected to rats four times every 30 minutes for 2 hours.
The liver was perfused with 0.9% NaCl, then removed and
washed in Krebs-Henseleit buffer, pH 7.4, containing 2
mM CaCl2 and 0.2% BSA. The pre-labeled liver was used
to obtain 10% homogenates and to analyze the14C-phos-
phoinositides. Besides, the slices of unlabeled liver were
labeled by incubation in the Eagle medium containing
10% fetal calf serum, 100 units/l streptomycin, 100 units/
l penicillin, 13 mg/ml gentamycin and 0.1 µCi/ml of mio-
[3H]inositol or 2.5 µCi/ml of [14C]oleic acid or 2.5 µCi/ml
[3H]arachidonic acid for 1–2 h in 95% O2/5% CO2 atmos-
phere at 37°C. The lipids were extracted and analyzed as
described below.
Cell Suspension Experiments
The hepatocytes were isolated from the liver by the
method described in [38]. Preparation of hepatocytes was
started between 9:00 and 10:00 a.m. The cells (107/ml)
were incubated in the Eagle medium containing 10% fetal
calf serum, 100 units/liter streptomycin, 100 units/liter
penicillin, 13 mg/ml gentamycin and in the presence of
100 nM NaOH (control) or L-T4(10 nM) for 30 min in
95% O2/5% CO2 atmosphere at 37°C. Before lipid extrac-
tion, the cells were washed twice with a Krebs-Henseleit
buffer pH 7.4, containing 2 mM CaCl2, 25 mM HEPES,
0.1% BSA. The lipids were extracted and analyzed as
described below.
Extraction and Separation of Lipids
The phospholipids were extracted according to Folch et al.
[39], the phosphoinositides as described in [40]. The
chloroform phase was collected and dried under N2 at
37°C. The lipids were redissolved in chloroform/metha-
nol (1:2, v/v) and applied on TLC plates. For a total phos-
pholipids isolation, the solvent system: hexane/diethyl
ether/acetic acid (80:20:2, v/v) was used, for PtdIns,
PtdInsP and PtdInsP2 – chloroform/methanol/NH4OH
(50:40:10, v/v). For phosphatidic acid separation the two-
dimensional TLC was used. The TLC plates were devel-
oped in chloroform/methanol/ NH4OH (60:35:5, v/v)
(first direction) and after – in the second direction in chlo-
roform/methanol/acetic acid/water (80:60:7.4:1.2, v/v).
The phospholipids masses were determined as described
in [41]. The gel spots containing [14C/3H]lipids wereLipids in Health and Disease 2004, 3:28 http://www.lipidworld.com/content/3/1/28
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scraped and transferred to the scintillation vials. Radioac-
tivity was measured by a scintillation counter.
Authors' contributions
NAB conceived of the study and participated in its design,
coordination, and manuscript preparation. OAK
participated in data collection and performed the statisti-
cal analysis.
References
1. Takenawa T, Itoh T: Phosphoinositides, key molecules for reg-
ulation of actin cytoskeletal organization and membrane
traffic from the plasma membrane. Biochim Biophys Acta 2001,
1533:190-206.
2. Martin TFJ: PI(4,5)P(2) regulation of surface membrane
traffic. Curr Opinion Cell Biol 2001, 13:493-499.
3. Koreh K, Monaco ME: The relationship of hormone-sensitive
and hormone-insensitive phosphatidylinositol to phosphati-
dylinositol 4,5-biphosphate in the WRK-1 cell. J Biol Chem 1986,
261:88-91.
4. Cubitt AB, Zhang B, Gershengorn MC: Analysis by base exchange
of thyrotropin-releasing hormone responsive and unrespon-
sive inositol lipid pools in rat pituitary tumor cells. J Biol Chem
1990, 265:9707-9714.
5. Heacock AM, Agranoff BW: CDP-diacylglycerol synthase from
mammalian tissues. Biochim Biophys Acta 1997, 1348:166-172.
6. Antonsson B: Phosphatidylinositol synthase from mammalian
tissues. Biochim Biophys Acta 1997, 1348:179-186.
7. Benjamins JA, Agranoff BW: Distribution and properties of CDP-
diacylglycerol:inositol  transferase from brain.  J Neurochem
1969, 16:513-527.
Long- and short-term effects of thyroxine on phosphoinositides metabolism in rat liver Figure 4
Long- and short-term effects of thyroxine on phosphoinositides metabolism in rat liver. Hormone rapidly and non-genomicaly 
stimulates PtdInsP2 degradation, DAG accumulation and PKC/PLD activation. Hormone-induced PLC activation is followed by 
PtdInsP2 resynthesis, probably via phosphoinositide 5-kinase induction by newly synthesized- or PCh-derived PA. PA could fur-
ther be converted to polyphosphoinositide precursor – arachidonate-contaning PtdIns under the long lag period of hormone 
action on the organism. PA – phosphatidic acid, CDP-DAG – cytidine diphosphate diacylglycerol, PAA – palmitic acid, AA – 
arachidonic acid, Ins – inositol, InsP – inositol 1-monophosphate, InsP2 – inositol 1,4-bisphosphate, InsP3 – inositol 1,4,5-tri-
sphosphate, PCh – phosphatidylcholine.
PtdIns PtdInsP PtdInsP2 PtdIns – PLC
DAG
+
T4
+
Ins InsP InsP2
PAA
InsP3
CDP-DAG
PKC
PA
+
T4
+
AA
glycerol-3-P
T4
+
+
PLD
+
PCh PAPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Lipids in Health and Disease 2004, 3:28 http://www.lipidworld.com/content/3/1/28
Page 10 of 10
(page number not for citation purposes)
8. Vaziri C, Downes CP, Macfarlane SC: Direct labelling of hor-
mone-sensitive phosphoinositides by a plasma-membrane-
associated PtdIns synthase in turkey erythrocytes. Biochem J
1993, 294:793-799.
9. Ledeen RW, Wu G: Nuclear lipids: key signaling effectors in
the nervous system and other tissues. J Lipid Res 2004, 45:1-8.
10. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll
PC, Woscholski R, Parker PJ, Waterfield MD: Synthesis and func-
tion of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001,
70:535-602.
11. Taker A: Phosphoinositides and signal transduction. Cell Mol
Life Sci 2002, 59:761-779.
12. Lykidis A, Jackson PD, Rock CO, Jackowski S: The role of CDP-dia-
cylglycerol synthetase and phosphatidylinositol synthase
activity levels in the regulation of cellular phosphatidylinosi-
tol content. J Biol Chem 1997, 272:33402-33409.
13. Saito S, Goto K, Tonosaki A, Kondo H: Gene cloning and charac-
terization of CDP-diacylglycerol synthase from rat brain. J
Biol Chem 1997, 272:9503-9509.
14. Monaco ME, Adelson JR: Evidence for coupling of resynthesis to
hydrolysis in the phosphoinositide cycle.  Biochem J 1991,
279:337-341.
15. Imai A, Gershengorn MC: Regulation by phosphatidylinositol of
rat pituitary plasma membrane and endoplasmic reticulum
phosphatidylinositol synthase activities.  J Biol Chem 1987,
262:6457-6459.
16. Jakab G, Kiss E, Kranias EG, Edes I: Effect of thyroid status on
phosphatidylinositols in rat heart.  Cardioscience 1993,
4(4):257-262.
17. Andersen PH, Juhl H, Pedersen SB, Richelsen B: Phosphoinositide
metabolism in adipocytes from hypothyroid rats.  Eur J
Pharmacol 1991, 206:81-85.
18. Iriuchijima T, Mizuma H, Michimata T, Ogiwara T, Yamada M,
Murakami M, Mori M: Thyroid hormone affects the hydrolysis
of inositol phospholipids in the rat hypothalamus. Neurosci Lett
1992, 134:275-278.
19. Iriuchijima T, Michimata T, Mizuma H, Murakami M, Yamada M, Mori
M: Hypothyroidism inhibits the formation of inositol phos-
phate in response to carbachol in the striatum of adult rat.
Res Commun Chem Pathol Pharmacol 1991, 73:173-180.
20. Kavok NS, Krasilnikova OA, Babenko NA: Thyroxine signaltrans-
duction in liver cells involves phospholipase C and phosphol-
ipase D activation. Genomic independent action of thyroid
hormone. BMC Cell Biology 2001, 2:5.
21. Krasilnikova OA, Kavok NS, Babenko NA: Role of calcium ions in
rapid effects L-thyroxine on phosphoinositide metabolism in
rat liver cells. Biochemistry (Moscow) 2003, 68:776-782.
22. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ: Thyroid hor-
mone induces activation of mitogen-activated protein kinase
in cultured cells. Am J Physiol 1999, 276(5 Pt 1):1014-1024.
23. Babenko NA, Kavok NS: Effect of thyroid hormones, phorbol
esters, and sphingosine on the incorporation of linoleic acid
into lipids in the liver of white rats.  Biokhimiya 1995,
60:1545-1550.
24. Kavok NS, Babenko NA: Effect of thyroid hormones, phorbol
esters, and sphingosine on the incorporation of linoleic acid
into lipids in the liver of white rats. Ukrainian Biochem J 2001,
73:80-84.
25. Cockcroft S: Phospholipase D: regulation by GTPases and pro-
tein kinase C and physiological relevance. Prog Lipid Res 1997,
35:345-370.
26. Pertile P, Liscovitch M, Chalifa V, Cantley LC: Phosphatidylinositol
4,5-bisphosphate synthesis is required for activation of phos-
pholipase D in U937 cells. J Biol Chem 1995, 270:5130-5135.
27. Jenco JM, Rawlingson A, Daniels B, Morris AJ: Regulation of phos-
pholipase D2: selective inhibition of mammalian phospholi-
pase D isoenzymes by α-and β-synucleins. Biochemistry 1998,
37:4901-4909.
28. Krasilnikova OA, Babenko NA: Role of thyroid hormones in reg-
ulation of phosphatidic acid, phosphatidylinositol and
polyphosphoinositide synthesis in liver cells.  Biochemistry
(Moscow) 1996, 61:1008-1014.
29. Apgar JR: Activation of protein kinase C in rat basophilic
leukemia cells stimulates increased production of phosphati-
dylinositol 4-phosphate and phosphatidylinositol 4,5-
bisphosphate: correlation with actin polymerization. Mol Biol
Cell 1995, 6:97-108.
30. Krasilnikova OA, Kavok NS, Babenko NA: Drug-induced and post-
natal hypothyroidism impairs the accumulation of diacylg-
lycerol in liver and liver cell plasma membranes.  BMC
Physiology 2002, 2:12.
31. Dang AQ, Faas FH, Carter WJ: Influence of hypo- and hyperthy-
roidism on rat liver glycerophospholipid metabolism. Lipids
1985, 20:897-902.
32. Moritz A, De Graan PNE, Gispen WH, Wirtz KWA: Phosphatidic
acid is a specific activator of phosphatidylinositol 4-phos-
phate kinase. J Biol Chem 1992, 267:7207-7210.
33. Hulbert AJ: Thyroid hormones and their effects: a new
perspective. Biol Rev 2000, 75:519-631.
34. Ruggiero FM, Landriscina C, Gnoni GV, Quagliariello E: Lipid com-
position of liver mitochondria and microsomes in hyperthy-
roid rats. Lipids 1984, 19:171-178.
35. Babenko NA, Kavok NS: Thyroid hormone regulation of phos-
pholipase A1 ans A2 acivity during ontogeny in rats: investiga-
tion of liver cells and their nuclei. Biochemistry (Moscow) 1994,
59:845-851.
36. Brent GA, Moore DD, Larsen PR: Thyroid hormone regulation
of gene expression. Annu Rev Physiol 1991, 53:17-35.
37. Lazar MA: Thyroid hormone receptors: multiple forms, mul-
tiple possibilities. Endocr Rev 1993, 14:184-193.
38. Gustavsson L, Moehern G, Torres-Marquez ME, Benistant C, Rubin
R, Hoek JB: The role of cytosolic Ca2+, protein kinase C and
protein kinase A in hormonal stimulation of phospholipase D
in rat hepatocytes. J Biol Chem 1994, 269:849-859.
39. Folch J, Lees M, Sloane Stanley GH: A simple method for the iso-
lation and purification of total lipid from animal tissues. Bio-
chem J 1957, 226:497-509.
40. Andrews WV, Conn PM: Measurement of inositol phospholipid
metabolites by one-dimensional thin-layer chromatography.
In In Methods in Enzimology Volume 141. New York: Academic Press,
Inc; 1987:156-158. 
41. Marsh JB, Weinstein DB: Simple charring method for determi-
nation of lipids. J Lipid Res 1966, 7:574-80.